[
  {
    "paperId": "3c03c8a179c5aa71b4d05c71add4f4d1a779f262",
    "title": "Genetic, clinical underpinnings of subtle early brain change along Alzheimer’s dimensions",
    "journal": "bioRxiv",
    "date": "2022-09-25",
    "doi": "10.1101/2022.09.16.508329",
    "brief": "It is shown that manifestations of brain changes in early asymptomatic stages can be detected via a novel deep semi-supervised representation learning method and deepen the understanding of the multifaceted pathogenesis of AD beyond the brain.",
    "authors": "J. Wen; Zhijian Yang; I. Nasrallah; Yuhan Cui; G. Erus; D. Srinivasan; A. Abdulkadir; E. Mamourian; G. Hwang; Ashutosh Kumar Singh; M. Bergman; J. Bao; E. Varol; Zhen Zhou; Aleix Boquet-Pujadas; Jiong Chen; A. Toga; A. Saykin; T. Hohman; P. Thompson; S. Villeneuve; R. Gollub; A. Sotiras; K. Wittfeld; H. Grabe; D. Tosun; M. Bilgel; Y. An; D. Marcus; Pamela J. LaMontagne; S. Heckbert; T. Austin; L. Launer; Mark Espeland; C. Masters; P. Maruff; J. Fripp; S. Johnson; J. Morris; M. Albert; R. Bryan; S. Resnick; L. Ferrucci; Yong Fan; M. Habes; D. Wolk; Li Shen; H. Shou; C. Davatzikos"
  },
  {
    "paperId": "4c12262c541dfe83dd9b9bd2df76e52596e3979a",
    "title": "Signs and symptoms associated with a need for supervision in patients with Alzheimer's disease",
    "journal": "medRxiv",
    "date": "2022-10-21",
    "doi": "10.1101/2022.10.20.22281336",
    "brief": "Clinicians and caregivers can aid clinicians and caregivers in prognosis and planning, suggest symptoms to target with non-pharmacological and pharmacological treatments to forestall this important functional milestone, and suggest priorities for future research.",
    "authors": "C. C. Huey; A. Kociolek; K. Fernandez; M. Hernandez; R. Gottesman; M. Barker; S. Cosentino; Y. Stern"
  },
  {
    "paperId": "1e322e06e5c786af35468613bb5c9f94b3e4173c",
    "title": "A multimodal intervention for Alzheimer's disease results in multifaceted systemic effects reflected in blood and ameliorates functional and cognitive outcomes",
    "journal": "medRxiv",
    "date": "2022-09-29",
    "doi": "10.1101/2022.09.27.22280385",
    "brief": null,
    "authors": "J. Roach; L. Edens; D. R. Markewych; M. Rapozo; J. Hara; Gustavo Glusman; C. Funk; J. Bramen; P. Baloni; W. Shankle; L. Hood"
  },
  {
    "paperId": "f04e3f0c7b995b8b31daf25529bd3a6f8b04d64a",
    "title": "Naturally occurring Alzheimer’s disease in rhesus monkeys",
    "journal": "bioRxiv",
    "date": "2022-10-21",
    "doi": "10.1101/2022.10.20.513120",
    "brief": null,
    "authors": "Zhenhui Li; Xiaping He; Shihao Wu; Rongyao Huang; Hao Li; Zhengbo Wang; Limin Wang; Dongdong Qin; Yu Kong; Yingqi Guo; Xia Ma; C. Turck; Zhiqi Xiong; Wenchao Wang; Xintian Hu"
  },
  {
    "paperId": "ab14b0e3396cc387b57fb4f12aae87fe20bb061d",
    "title": "Brain and systemic inflammation in de novo Parkinson's disease",
    "journal": "medRxiv",
    "date": "2022-09-23",
    "doi": "10.1101/2022.09.21.22280194",
    "brief": "18F-DPA-714 imaging demonstrated increased central inflammation in de novo PD subjects compared to controls, and longitudinal follow-up will be important to determine whether the presence of inflammation predicts cognitive decline.",
    "authors": "T. Yacoubian; Yaxiu Fang; A. Gerstenecker; A. Amara; N. Stover; L. Ruffrage; C. Collete; R. Kennedy; Y. Zhang; H. Hong; H. Qin; J. McConathy; E. Benveniste; D. Standaert"
  },
  {
    "paperId": "8fd1cdcc45e1a022db2f62668c860f155a0c021c",
    "title": "Resilience and resistance to Alzheimer's disease-associated neuropathological substrates in centenarians: an age-continuous perspective",
    "journal": "medRxiv",
    "date": "2022-08-30",
    "doi": "10.1101/2022.08.28.22279304",
    "brief": "With age, brains from non-demented individuals reached NIA-Amyloid and Braak-NFT stages as observed in AD patients, while CERAD-NP scores remained lower.",
    "authors": "M. Zhang; A. Ganz; S. Rohde; A. Rozemuller; M. Reinders; P. Scheltens; M. Hulsman; J. Hoozemans; H. Holstege"
  },
  {
    "paperId": "4ec24704ddce77e0cacbee05c754f6ff105ba837",
    "title": "Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study",
    "journal": "medRxiv",
    "date": "2022-09-09",
    "doi": "10.1101/2022.09.07.22279676",
    "brief": "P-tau/A{beta}42 is sufficient for predicting progression in AD, with very high accuracy, and adding NfL improves the prediction of all-cause dementia conversion and cognitive decline.",
    "authors": "G. Salvadó; V. Larsson; K. Cody; N. Cullen; E. Jonaitis; E. Stomrud; G. Kollmorgen; N. Wild; S. Palmqvist; S. Janelidze; N. Mattsson-Carlgren; H. Zetterberg; K. Blennow; S. Johnson; R. Ossenkoppele; O. Hansson"
  },
  {
    "paperId": "0599fd660a6eeb4d478fee58b7861c2495685128",
    "title": "Association between Serum Biomarker Profile and Real-World Evidence of Disability in Multiple Sclerosis",
    "journal": "medRxiv",
    "date": "2022-10-22",
    "doi": "10.1101/2022.10.21.22281364",
    "brief": "Serumprotein biomarker profiles improve the prediction of real-world MS disability status beyond clinical profile alone or clinical profile plus individual protein biomarker, reaching clinically actionable performance.",
    "authors": "W. Zhu; C. Chen; L. Zhang; T. Hoyt; E. Walker; S. Venkatesh; F. Zhang; F. Qureshi; J. Foley; Z. Xia"
  },
  {
    "paperId": "0282ceca0416679906f45a9eb22b6aaf69c2610a",
    "title": "Plasma phosphorylated tau 181 predicts amyloid status and conversion from mild cognitive impairment to dementia stage; major impact of renal function on diagnostic performance in the BALTAZAR cohort",
    "journal": "medRxiv",
    "date": "2022-09-17",
    "doi": "10.1101/2022.09.13.22279818",
    "brief": "Chronic kidney disease, creatinine and glomerular filtration rate were independently associated with plasma P-tau181 concentrations, thereby altering the optimal cutpoints for A{beta}+ or conversion to dementia detection, making this blood biomarker central to AD management.",
    "authors": "S. Lehmann; S. Schraen-Maschke; J. Vidal; C. Delaby; F. Blanc; C. Paquet; B. Allinquant; S. Bombois; A. Gabelle; O. Hanon"
  },
  {
    "paperId": "0a1d1dbe660b7cf893a58278cf3bce3c493fb6d6",
    "title": "Associations between affective/vegetative neuropsychiatric symptoms and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.",
    "journal": "medRxiv",
    "date": "2022-10-07",
    "doi": "10.1101/2022.10.05.22280745",
    "brief": "Findings show the implication of fronto-temporal regions with sleep disorders, depression and appetite changes, and contribute to a better understanding of brain morphological differences between CN, MCI and AD with respect to all five NPS.",
    "authors": "A. Cannizzaro; L. Ronat; L. M. El Haffaf; A. Hanganu"
  },
  {
    "paperId": "fa3415454e7a8019fbb8958d8f835d2c12480c6e",
    "title": "Statistical Evaluation of the Test Threshold for the Alzheimer's Disease EEG Coherence Marker",
    "journal": "medRxiv",
    "date": "2022-09-09",
    "doi": "10.1101/2022.09.07.22279698",
    "brief": "If synaptic disconnection as the neuropathology of Alzheimer's disease (AD) is responsible for the brain's inability to integrate diverse regions into efficient networks, then electroencephalographic data may be utilized to identify Alzheimer's dementia.",
    "authors": "C. Radinski; G. Perez"
  },
  {
    "paperId": "b247cb175b15b95598f2025364b9a77160988fad",
    "title": "What does heritability of Alzheimer’s disease represent?",
    "journal": "bioRxiv",
    "date": "2022-09-08",
    "doi": "10.1101/2022.09.07.506912",
    "brief": "Estimates of heritability in Alzheimer’s disease, the proportion of phenotypic variance explained by genetics, are very varied across different studies, therefore, the amount of ‘missing’ heritability not yet captured by current genome-wide association studies is debated.",
    "authors": "E. Baker; G. Leonenko; K. Schmidt; M. Hill; A. Myers; M. Shoai; I. de Rojas; N. Tesi; H. Holstege; W. M. van der Flier; Y. Pijnenburg; A. Ruiz; J. Hardy; S. J. van der Lee; V. Escott-Price"
  },
  {
    "paperId": "0ff3203ce696ae5cea0b682d11f20af02f562646",
    "title": "Exploration of cortical Î²-Amyloid load in Alzheimer's disease using quantitative susceptibility mapping at 9.4T",
    "journal": "medRxiv",
    "date": "2022-09-25",
    "doi": "10.1101/2022.09.23.22280290",
    "brief": "This explorative study points toward the development of more accessible clinical methods to non-invasively detect effects of A{beta} accumulation in AD patients by exploring cortical features that can be detected by ultra-high field QSM at different spatial resolutions.",
    "authors": "E. Tuzzi; A. Loktyushin; A. Zeller; R. Pohmann; C. Laske; K. Scheffler; G. Hagberg"
  },
  {
    "paperId": "01b5569a34603fafb2e825d6e06515c87e905319",
    "title": "Disrupted role of the connectivity between the locus coeruleus and the hippocampus in cognition of healthy, middle-aged individuals at risk of dementia: the PREVENT-Dementia study",
    "journal": "medRxiv",
    "date": "2022-09-02",
    "doi": "10.1101/2022.09.02.22279541",
    "brief": "Light is shed on the brain mechanism of incipient AD neuropathology in individuals, who are at high risk for late-life dementia on the cardiovascular risk score, but presently cognitively healthy.",
    "authors": "F. Deng; Maria-Eleni Dounavi; K. Ritchie; G. Muniz-Terrera; P. Malhotra; C. Ritchie; B. Lawlor; L. Naci"
  },
  {
    "paperId": "d716acdc41b829b0038890723f394e688a2542e8",
    "title": "Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Biomarker Proteins Reveals Stage-Specific Changes in Alzheimer's Disease",
    "journal": "medRxiv",
    "date": "2022-09-01",
    "doi": "10.1101/2022.08.30.22279370",
    "brief": "A sensitive, quantitative, and scalable targeted proteomics assay of AD biomarkers representing mainly neuronal, glial, vasculature and metabolic pathways is reported, highlighting the utility of high-throughput SRM-MS to quantify peptide biomarkers in CSF that can potentially monitor disease progression.",
    "authors": "C. M. Watson; E. Dammer; L. Ping; D. Duong; E. Modeste; E. K. Carter; E. Johnson; A. Levey; J. Lah; B. Roberts; N. Seyfried"
  },
  {
    "paperId": "3f5ddc694fdc8bc128e8741d9888118221b8a0d1",
    "title": "Hierarchical Two-Stage Cost-Sensitive Clinical Decision Support System for Screening Prodromal Alzheimer's Disease and Related Dementias",
    "journal": "medRxiv",
    "date": "2022-09-09",
    "doi": "10.1101/2022.09.06.22279650",
    "brief": "The primary stage is brief and effective at screening, with the optional two- stage technique further increasing specificity, and the hierarchical two-stage technique exhibited similar accuracy but with reduced costs compared to the more common single-stage paradigm.",
    "authors": "M. Kleiman; T. Ariko; J. Galvin"
  },
  {
    "paperId": "e7da2e1f4e3deb5b18b5cc2515033bb9961d91f8",
    "title": "Prediction of misfolded proteins spreading in Alzheimer’s disease using machine learning",
    "journal": "bioRxiv",
    "date": "2022-10-07",
    "doi": "10.1101/2022.10.04.510701",
    "brief": "The proposed method applies an autoregressive model, constrained by structural connectivity, to predict concentrations of Amyloid-β two years after the provided baseline, and outperformed the state-of-art models yielding the lowest average prediction error.",
    "authors": "L. Gherardini; Aleksandra Pestka; Lorenzo Pini; A. Crimi"
  },
  {
    "paperId": "b600a055922dea8d2f5b748daab8b64a78457292",
    "title": "Neurodegenerative disease associated pathways in brain of the triple transgenic Alzheimer’s model are reversed in vivo following two weeks peripheral administration of fasudil",
    "journal": "bioRxiv",
    "date": "2022-10-03",
    "doi": "10.1101/2022.09.30.510301",
    "brief": "The results bolster the repurposing potential of fasudil by demonstrating an anti-neurodegenerative phenotype in a disease context and highlight the potential of in vivo transcriptional profiling of drug activity.",
    "authors": "R. Killick; C. Elliott; E. Ribe; M. Broadstock; C. Ballard; D. Aarsland; Gareth Williams"
  },
  {
    "paperId": "96f88ce9c1b5dc6e9ce524512095c349c399589c",
    "title": "CHRNA5 links chandelier cells to protection against amyloid pathology in human aging and Alzheimer’s Disease",
    "journal": "bioRxiv",
    "date": "2022-08-30",
    "doi": "10.1101/2022.05.03.490491",
    "brief": "Findings suggest that CHRNA5 and its nicotinic α5 subunit exert a neuroprotective role in aging and Alzheimer’s disease potentially centered on chandelier interneurons.",
    "authors": "Jonas Rybnicek; Yuxiao Chen; Milos Millic; J. McLaurin; P. D. De Jager; J. Schneider; Yanling Wang; David A. Bennett; S. Tripathy; D. Felsky; E. Lambe"
  },
  {
    "paperId": "5c719dba8b594ea346f0b2fc4d8eeb5d607bc2c7",
    "title": "Synthesizing Images of Tau Pathology from Cross-modal Neuroimaging using Deep Learning",
    "journal": "bioRxiv",
    "date": "2022-09-12",
    "doi": "10.1101/2022.09.07.507042",
    "brief": "A convolutional neural network model is presented that can impute tau PET images with high accuracy and suggests that extending neuroimaging’s use with artificial intelligence to predict protein specific pathologies has great potential to inform emerging care models.",
    "authors": "Jeyeon Lee; B. Burkett; Hoon-Ki Min; M. Senjem; Ellen Dicks; Nick Corriveau-Lecavalier; Carly T. Mester; H. Wiste; E. Lundt; M. Murray; A. Nguyen; R. Reichard; H. Botha; J. Graff‐Radford; L. Barnard; J. Gunter; C. Schwarz; K. Kantarci; D. Knopman; B. Boeve; V. Lowe; R. Petersen; C. Jack; David T. Jones"
  },
  {
    "paperId": "7b5572f5c3481334ae57375036f5f77cfadcce11",
    "title": "Cerebrospinal fluid neurofilament light improves accurate distinction between neurodegenerative and psychiatric disorders at a cognitive neuropsychiatry service",
    "journal": "medRxiv",
    "date": "2022-09-09",
    "doi": "10.1101/2022.09.08.22279663",
    "brief": "Cerebrospinal fluid neurofilament light improved diagnostic accuracy, with potential to have led to earlier, accurate diagnosis in a real-world setting using a pre-specified cut-off, adding weight to translation of NfL into clinical practice.",
    "authors": "M. Kang; D. Eratne; H. Dobson; C. Malpas; M. Keem; C. Lewis; J. Grewal; V. Tsoukra; C. Dang; R. Mocellin; T. Kalincik; A. Santillo; H. Zetterberg; K. Blennow; C. Stehmann; S. Varghese; Q.-X. Li; C. Masters; S. Collins; S. Berkovic; A. Evans; W. Kelso; S. Farrand; S. Loi; M. Walterfang; D. Velakoulis"
  },
  {
    "paperId": "6f902f4ee0f248dbdfad0cb19de361601e1c2b77",
    "title": "Adapting UK Biobank imaging for use in a routine memory clinic setting: the Oxford Brain Health Clinic",
    "journal": "medRxiv",
    "date": "2022-09-01",
    "doi": "10.1101/2022.08.31.22279212",
    "brief": "This work adapted the UKB MRI acquisition protocol to be suitable for memory clinic patients, modified the imaging analysis pipeline to extract measures that are in line with radiology reports, and compared measures from BHC patients to the largest brain MRI study in the world (ultimately 100,000 participants).",
    "authors": "L. Griffanti; G. Gillis; M. C. O’Donoghue; J. Blane; P. Pretorius; R. Mitchell; N. Aikin; K. Lindsay; J. Campbell; J. Sample; F. Alfaro-Almagro; S. M. Smith; K. Miller; L. Martos; V. Raymont; C. Mackay"
  }
]